Stefano Pessina

Walgreens Boots to Sell Unit to AmerisourceBergen
M&A

Walgreens Boots to Sell Unit to AmerisourceBergen

The $6.5 billion sale of the Alliance Healthcare pharmacy distribution will enable Walgreens to focus on its core retail operations.
By Matthew Heller | January 6, 2021
Read More
Walgreens Swings to Loss as COVID Hits Sales
Financial Performance

Walgreens Swings to Loss as COVID Hits Sales

The pandemic had an adverse impact on sales in the third quarter of about $700 million to $750 million though sales rose in the U.S.
By Matthew Heller | July 9, 2020
Read More
Walgreens Shares Dive on Q1 Earnings Miss
Financial Performance

Walgreens Shares Dive on Q1 Earnings Miss

“We anticipate that profitability and sales growth may be hard to come by for the foreseeable future,” an analyst says of the drugstore chain.
By Matthew Heller | January 8, 2020
Read More
Walgreens Stock Jumps 4% on Earnings Beat
Financial Performance

Walgreens Stock Jumps 4% on Earnings Beat

“Following a difficult second quarter, we made progress in the third quarter against the strategic goals we set," CEO Stefano Pessina says.
By Matthew Heller | June 27, 2019
Read More
Walgreens Slashes 2019 Outlook, Shares Dip 12%
Financial Performance

Walgreens Slashes 2019 Outlook, Shares Dip 12%

The company's second-quarter report showed the continuing impact of shrinking generic drug sales on the country's largest pharmacy chains.
By Matthew Heller | April 2, 2019
Read More
Pharmacy Sales Prescribe Growth for Walgreens
Strategy

Pharmacy Sales Prescribe Growth for Walgreens

The drugstore chain's pharmacy same-store sales rose 5.1% in Q2, offsetting a 2.7% drop in retail comparable sales.
By Matthew Heller | March 28, 2018
Read More
After Merger, Walgreens Plans $1.5B in Cost Cuts
Strategy

After Merger, Walgreens Plans $1.5B in Cost Cuts

The focus is on operations for the newly global company, which will close 200 U.S. stores.
By Katie Kuehner-Hebert | April 9, 2015
Read More